Jefferies Initiates Coverage of Sarepta Therapeutics (LSE:0L35) with Buy Recommendation
Source: NASDAQ Stocks / 22 Oct 2024 04:04:44 America/New_York
Fintel reports that on October 21, 2024, Jefferies initiated coverage of Sarepta Therapeutics (LSE:0L35) with a Buy recommendation.
https://www.nasdaq.com/articles/jefferies-initiates-coverage-sarepta-therapeutics-lse-0l35-buy-recommendation